NanoSyrinx Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.98M
- Investors
-
16
NanoSyrinx General Information
Description
Developer of a novel biologics drug research platform designed to serve the biopharmaceutical sector. The company leverages a synthetic biology approach to create a completely novel method for targeted drug delivery of therapeutic proteins and peptides to cell interiors and delivers payloads directly to the cytosol of targeted cells, enabling medical practitioners to improve efficacy and treatment outcomes.
Contact Information
Website
www.nanosyrinx.comCorporate Office
- Unit 27D, The Venture Centre, Sir William Lyons Road
- University of Warwick Science Park, West Midlands
- Coventry CV4 7EZ
- England, United Kingdom
Corporate Office
- Unit 27D, The Venture Centre, Sir William Lyons Road
- University of Warwick Science Park, West Midlands
- Coventry CV4 7EZ
- England, United Kingdom
NanoSyrinx Timeline
NanoSyrinx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 28-Nov-2025 | $4.98M | Completed | Product Development | ||
| 5. Later Stage VC (Series A) | 13-Aug-2024 | Completed | Product Development | |||
| 4. Seed Round | 10-Nov-2022 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jul-2020 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
NanoSyrinx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Seed Ordinary | ||||||||
| Seed Ordinary | 2,875,900 | $0.000001 | $2.16 | $2.16 | 1x | $2.16 | 43.63% | |
| Seed Ordinary | 328,100 | $0.000001 | $1.3 | $1.3 | 1x | $1.3 | 4.98% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NanoSyrinx Comparisons
Industry
Financing
Details
NanoSyrinx Competitors (2)
One of NanoSyrinx’s 2 competitors is Therapeutic Peptides, a Corporate Backed or Acquired company based in Baton Rouge, LA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Therapeutic Peptides | Corporate Backed or Acquired | Baton Rouge, LA | ||||
| Immupharma | Corporation | London, United Kingdom |
NanoSyrinx Patents
NanoSyrinx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202509404-D0 | A modified tail fibre | Pending | 13-Jun-2025 | ||
| GB-202417349-D0 | Method of purification | Pending | 26-Nov-2024 | ||
| WO-2026115259-A1 | Method of purification | Pending | 26-Nov-2024 | ||
| AU-2020288380-A1 | Leader sequence | Active | 07-Jun-2019 | ||
| AU-2020288380-B2 | Leader sequence | Active | 07-Jun-2019 | C07K14/195 |
NanoSyrinx Signals
NanoSyrinx Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Proven Connect | Impact Investing | Minority | ||
| Saras Capital (England) | Venture Capital | Minority | ||
| BGF (Financial Services) | Growth/Expansion | Minority | ||
| Lilly USA | Corporation | Minority | ||
| Alderley Park | Accelerator/Incubator | Minority |
NanoSyrinx FAQs
-
When was NanoSyrinx founded?
NanoSyrinx was founded in 2018.
-
Where is NanoSyrinx headquartered?
NanoSyrinx is headquartered in Coventry, United Kingdom.
-
What is the size of NanoSyrinx?
NanoSyrinx has 21 total employees.
-
What industry is NanoSyrinx in?
NanoSyrinx’s primary industry is Drug Delivery.
-
Is NanoSyrinx a private or public company?
NanoSyrinx is a Private company.
-
What is the current valuation of NanoSyrinx?
The current valuation of NanoSyrinx is .
-
What is NanoSyrinx’s current revenue?
The current revenue for NanoSyrinx is .
-
How much funding has NanoSyrinx raised over time?
NanoSyrinx has raised $25M.
-
Who are NanoSyrinx’s investors?
Proven Connect, Saras Capital (England), BGF (Financial Services), Lilly USA, and Alderley Park are 5 of 16 investors who have invested in NanoSyrinx.
-
Who are NanoSyrinx’s competitors?
Therapeutic Peptides and Immupharma are competitors of NanoSyrinx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process